 Seagen is a phenomenal innovation success story that delivers hope to patients afflicted by deadly cancers while also rewarding shareholders. The approved therapeutics should generate at least 1.6B in revenue this year. Due to various ongoing label expansions, you can expect a much stronger top-line growth rate. 